TriSalus Life Sciences (TLSI) Research & Development (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Research & Development of $7.4 million for Q1 2026, up 10.08% year-over-year from $6.7 million in Q1 2025, and up 228.45% quarter-over-quarter from -$5.8 million in Q4 2025.
TriSalus Life Sciences (TLSI) Research & Development (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Research & Development history runs 5 years deep, the most recent figure standing at $7.4 million for Q1 2026.
- In Q1 2026, Research & Development rose 10.08% year-over-year to $7.4 million; the TTM figure through Mar 2026 stood at $12.4 million (down 55.81% YoY), while the FY2025 annual figure was $15.0 million, down 42.08% from the prior year.
- Research & Development for Q1 2026 stood at $7.4 million, up from -$5.8 million in the prior quarter.
- The five-year high for Research & Development was $12.5 million in Q4 2022, with the low at -$5.8 million in Q4 2025.
- The 5-year median for Research & Development is $6.0 million (2024), against an average of $5.9 million.
- The sharpest annual moves came in 2023 and 2025: Research & Development jumped 213.73% in 2023, then sank 151.94% in 2025.
- TriSalus Life Sciences' Research & Development stood at $12.5 million in 2022, then slumped by 37.73% to $7.8 million in 2023, then jumped by 43.0% to $11.1 million in 2024, then sank by 151.94% to -$5.8 million in 2025, then soared by 228.45% to $7.4 million in 2026.
- Business Quant data shows TLSI's Research & Development at $7.4 million in Q1 2026, -$5.8 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 28.60 Mn |
| 10 | TriSalus Life Sciences | 307.64 Mn | 261.36 Mn | 9.90 Mn | 11.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.42 Mn |
| Mar 31, 2026 | 7.41 Mn |
| Dec 31, 2025 | -5.77 Mn |
| Sep 30, 2025 | 6.84 Mn |
| Jun 30, 2025 | 3.92 Mn |
| Mar 31, 2025 | 6.73 Mn |
| Dec 31, 2024 | 11.11 Mn |
| Sep 30, 2024 | 4.22 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 5.84 Mn |
| Dec 31, 2023 | 7.77 Mn |
| Sep 30, 2023 | 9.51 Mn |
| Jun 30, 2023 | 3.49 Mn |
| Mar 31, 2023 | 5.64 Mn |
| Dec 31, 2022 | 12.48 Mn |
| Sep 30, 2022 | 3.03 Mn |